enVVeno Medical wins FDA IDE for non-surgical transcatheter replacement venous valve
July 31, 2026
enVVeno Medical (Nasdaq:NVNO) announced today that it received FDA investigational device exemption (IDE) for its enVVe system.
enVVeno Medical (Nasdaq:NVNO) announced today that it received FDA investigational device exemption (IDE) for its enVVe system.
New medium-cutoff Dialyzer with a Super High-flux membrane brings NIPRO’s approach to expanded hemodialysis to United States healthcare providers.
Total Flow Medical announced today that it received FDA 510(k) clearance for its TFA femoral arterial cannula device.
Medical Microinstruments (MMI) announced today that the FDA approved a supplement to a study of its surgical robot in Alzheimer’s.
CorVista’s AI-based pulmonary capillary wedge pressure add-on test represents the third FDA clearance for its cardiopulmonary platform.
Saber-C AVIA is a zero-profile construct providing biomechanical stability similar to that of traditional plate systems.
Smith+Nephew (NYSE:SNN) announced today that the FDA granted de novo clearance for its TESSA spatial surgery system.
The PicoPretty device seamlessly integrates Picosecond, Long Pulse, and Genesis technologies to provide unparalleled versatility
With regulatory clearance in place, FIZE Medical expands its global commercial footprint across Europe and the UK alongside existing operations in North America and Japan
New AI-powered algorithm delivers more personalized birth control by adapting to individual cycle patterns while maintaining established effectiveness rates